CN112105721A - 内皮细胞因子及其方法 - Google Patents

内皮细胞因子及其方法 Download PDF

Info

Publication number
CN112105721A
CN112105721A CN201980020598.1A CN201980020598A CN112105721A CN 112105721 A CN112105721 A CN 112105721A CN 201980020598 A CN201980020598 A CN 201980020598A CN 112105721 A CN112105721 A CN 112105721A
Authority
CN
China
Prior art keywords
cells
endothelial
niche
hspcs
family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980020598.1A
Other languages
English (en)
Chinese (zh)
Inventor
伦纳德·I·索恩
艾略特·J·哈格多恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of CN112105721A publication Critical patent/CN112105721A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1171—Haematopoietic stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN201980020598.1A 2018-03-23 2019-03-22 内皮细胞因子及其方法 Pending CN112105721A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862647433P 2018-03-23 2018-03-23
US62/647,433 2018-03-23
PCT/US2019/023637 WO2019183508A1 (en) 2018-03-23 2019-03-22 Endothelial cell factors and methods thereof

Publications (1)

Publication Number Publication Date
CN112105721A true CN112105721A (zh) 2020-12-18

Family

ID=67987596

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980020598.1A Pending CN112105721A (zh) 2018-03-23 2019-03-22 内皮细胞因子及其方法

Country Status (6)

Country Link
US (2) US12146165B2 (https=)
EP (1) EP3768282A4 (https=)
JP (2) JP7455067B2 (https=)
CN (1) CN112105721A (https=)
CA (1) CA3094837A1 (https=)
WO (1) WO2019183508A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118834915A (zh) * 2024-08-15 2024-10-25 扬州大学 一种在羊毛乳头细胞中稳定过表达的sox18慢病毒重组标签载体的构建及应用

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025096798A2 (en) * 2023-10-31 2025-05-08 The Children's Medical Center Corporation Endothelial cell factors and methods thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227352A1 (en) * 2004-04-09 2005-10-13 Stowers Institute For Medical Research Use of BMP (BAM) signaling to control stem cell fate determination
US20120207744A1 (en) * 2009-03-19 2012-08-16 Mendlein John D Reprogramming compositions and methods of using the same
US20130243736A1 (en) * 2012-01-27 2013-09-19 Sapporo Medical University Replacement of bone marrow niche cells for treatment of various diseases
US20140162366A1 (en) * 2012-08-31 2014-06-12 Salk Institute For Biological Studies Generation of vascular progenitor cells
WO2016201133A2 (en) * 2015-06-09 2016-12-15 The Regents Of The University Of California Hematopoietic cells and methods of using and generating the same
WO2017015245A1 (en) * 2015-07-20 2017-01-26 Angiocrine Bioscience, Inc. Methods and compositions for stem cell transplantation
CN107249607A (zh) * 2014-12-19 2017-10-13 安吉克莱茵生物科学有限公司 包括工程化内皮细胞的生物相容性植入物
US20180010124A1 (en) * 2012-10-22 2018-01-11 Wisconsin Alumni Research Foundation Induction of Hemogenic Endothelium from Pluripotent Stem Cells by Forced Expression of Transcription Factors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009042910A2 (en) 2007-09-26 2009-04-02 University Of South Florida Ship inhibition to direct hematopoietic stem cells and induce extramedullary hematopoiesis
JP5139271B2 (ja) 2005-05-24 2013-02-06 ホワイトヘッド インスティチュート フォー バイオメディカル リサーチ 培養した造血幹細胞を拡大しかつ分析する方法
GB201212111D0 (en) * 2012-07-06 2012-08-22 Gmbh Vascular bed-specific endothelial cells
JP6581906B2 (ja) * 2013-01-15 2019-09-25 コーネル ユニヴァーシティー 確定因子によるヒト内皮の造血性多系列前駆細胞へのリプログラミング
CN108291196B (zh) * 2015-07-20 2021-08-27 安吉克莱茵生物科学有限公司 表达ets转录因子的工程化的内皮细胞

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227352A1 (en) * 2004-04-09 2005-10-13 Stowers Institute For Medical Research Use of BMP (BAM) signaling to control stem cell fate determination
US20120207744A1 (en) * 2009-03-19 2012-08-16 Mendlein John D Reprogramming compositions and methods of using the same
US20130243736A1 (en) * 2012-01-27 2013-09-19 Sapporo Medical University Replacement of bone marrow niche cells for treatment of various diseases
US20140162366A1 (en) * 2012-08-31 2014-06-12 Salk Institute For Biological Studies Generation of vascular progenitor cells
US20180010124A1 (en) * 2012-10-22 2018-01-11 Wisconsin Alumni Research Foundation Induction of Hemogenic Endothelium from Pluripotent Stem Cells by Forced Expression of Transcription Factors
CN107249607A (zh) * 2014-12-19 2017-10-13 安吉克莱茵生物科学有限公司 包括工程化内皮细胞的生物相容性植入物
WO2016201133A2 (en) * 2015-06-09 2016-12-15 The Regents Of The University Of California Hematopoietic cells and methods of using and generating the same
WO2017015245A1 (en) * 2015-07-20 2017-01-26 Angiocrine Bioscience, Inc. Methods and compositions for stem cell transplantation

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
HAGEDORN, ELLIOTT J.等: "Defining the Transcriptional Code That Specifies Sinusoidal Endothelial Cells in the HSPC Niche", 《BLOOD》, vol. 130, pages 1 - 2 *
MAESTRE, INÉS FERNÁNDEZ: "Elucidating the Transcriptional Program Specifying Endothelial Cells in the Zebrafish Blood Stem Cell Niche", MASTER THESIS OF UNIVERSITY OF APPLIED SCIENCES TECHNIKUM WIEN, pages 1 - 132 *
PARK C等: "Transcriptional regulation of endothelial cell and vascular development", 《CIRC RES》, vol. 112, no. 10, pages 1380 - 1400, XP055547751, DOI: 10.1161/CIRCRESAHA.113.301078 *
PERLIN, J.R.等: "Blood on the tracks: hematopoietic stem cell-endothelial cell interactions in homing and engraftment", 《J MOL MED》, vol. 95, pages 809 - 819, XP036279062, DOI: 10.1007/s00109-017-1559-8 *
YOU LR等: "Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity", 《NATURE》, vol. 435, no. 7038, pages 98 - 104 *
张开滋等: "《骨髓纤维化中西医结合治疗》", vol. 2014, 湖南科学技术出版社, pages: 781 - 785 *
杜华等: "骨髓微环境对造血干细胞命运的调控", 《中国组织工程研究》, vol. 19, no. 14, pages 2283 - 2290 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118834915A (zh) * 2024-08-15 2024-10-25 扬州大学 一种在羊毛乳头细胞中稳定过表达的sox18慢病毒重组标签载体的构建及应用

Also Published As

Publication number Publication date
JP2024075624A (ja) 2024-06-04
JP7683068B2 (ja) 2025-05-26
US20240417695A1 (en) 2024-12-19
JP2021518143A (ja) 2021-08-02
JP7455067B2 (ja) 2024-03-25
WO2019183508A1 (en) 2019-09-26
EP3768282A1 (en) 2021-01-27
CA3094837A1 (en) 2019-09-26
US12146165B2 (en) 2024-11-19
US20210079343A1 (en) 2021-03-18
EP3768282A4 (en) 2021-12-08

Similar Documents

Publication Publication Date Title
Fish et al. Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network
Ellis et al. Targeting tumor angiogenesis with histone deacetylase inhibitors
Aimé et al. Trib3 is elevated in Parkinson's disease and mediates death in Parkinson's disease models
Yousefi et al. Msi RNA-binding proteins control reserve intestinal stem cell quiescence
JP7683068B2 (ja) 内皮細胞因子およびその方法
US20210008070A1 (en) Targeting minimal residual disease in cancer with cd36 antagonists
Wen et al. RORβ suppresses the stemness of gastric cancer cells by downregulating the activity of the Wnt signaling pathway
Xiao et al. Endothelial Brg1 fine-tunes Notch signaling during zebrafish heart regeneration
Lai et al. Spinal RNF20-mediated histone H2B monoubiquitylation regulates mGluR5 transcription for neuropathic allodynia
Schmitt et al. Functional synapses between small cell lung cancer and glutamatergic neurons
US20210010089A1 (en) Tumor minimal residual disease stratification
US20210008047A1 (en) Targeting minimal residual disease in cancer with rxr antagonists
Zhang et al. Genome writing to dissect consequences of SVA retrotransposon disease X-Linked Dystonia Parkinsonism
EP4680976A1 (en) Methods and uses involving aquaporin-5 (aqp5)
WO2025096798A2 (en) Endothelial cell factors and methods thereof
JPWO2005063301A1 (ja) Ｅｍｔ誘導剤
US9435809B2 (en) Method of treating and reducing the risk of acute myelogenous leukemia
US20240350581A1 (en) Methods for treatment of neuron degeneration
Wang et al. FTO-mediated m6A modification regulates the osteogenic differentiation of ADSCs by targeting FOXO1
Al Reza The Role of Forkhead Box F1 Transcription Factor in Mesenchymal-Epithelial Signaling During Lung Development
Rui et al. Inhibition of BRG1 suppresses the progression of glioblastoma via repressing oligodendrocyte genes
Arévalo Bautista The role of stat3 phosphorylation state in clear cell renal cell carcinoma (ccRCC)
Yin et al. Identification of CD34+ ABCA3+ Cells as the Origin of Lung Adenocarcinoma Through the Interaction between Lung Progenitor Club and Lgr6 Cells
CN102512436B (zh) 一种具有协同作用的治疗t(11;17)急性早幼粒细胞白血病的组合药物及其应用
Myers Origins and development of the embryonic vascular system in Xenopus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination